Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Non-Current Deffered Revenue (2019 - 2025)

Outset Medical (OM) has disclosed Non-Current Deffered Revenue for 7 consecutive years, with $406000.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 51.9% to $406000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $406000.0 through Dec 2025, down 51.9% year-over-year, with the annual reading at $406000.0 for FY2025, 51.9% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $406000.0 at Outset Medical, down from $676000.0 in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $844000.0 in Q4 2024, with the low at $77000.0 in Q3 2024.
  • Average Non-Current Deffered Revenue over 5 years is $313950.0, with a median of $190000.0 recorded in 2022.
  • The sharpest move saw Non-Current Deffered Revenue plummeted 80.74% in 2021, then soared 777.92% in 2025.
  • Over 5 years, Non-Current Deffered Revenue stood at $312000.0 in 2021, then plummeted by 51.6% to $151000.0 in 2022, then crashed by 33.11% to $101000.0 in 2023, then skyrocketed by 735.64% to $844000.0 in 2024, then tumbled by 51.9% to $406000.0 in 2025.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $406000.0, $676000.0, and $587000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.